May 13, 2022 -- Emmes will unveil the third generation of its Advantage eClinical software at the Society for Clinical Trials annual meeting in San Diego. This newly updated program functions as a standalone cloud software product, with improved utility and insights for clinical trial sponsors.
The platform comes equipped with apps related to study design, electronic data capture, randomization and trial supply management, patient-reported outcomes, safety data and reporting, risk monitoring, source data verification, and specimen tracking. The platform will be available for purchase alongside data consultation services or as a standalone product.
This new version of Advantage eClinical enables higher quality data and facilitates the oversight of clinical trials in a timely manner, reducing costs as well. Furthermore, the new platform promotes rapid study builds with greater flexibility for a variety of clinical trial sponsor companies.
Copyright © 2022 scienceboard.net